WallStSmart
RDHL

Redhill Biopharma Ltd

NASDAQ: RDHL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.04
+0.00% today

Updated 2026-04-29

Market cap
$5.27M
P/E ratio
0.00
P/S ratio
0.55x
EPS (TTM)
$0.00
Dividend yield
52W range
$1 – $3
Volume
0.0M

Redhill Biopharma Ltd (RDHL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.3%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-5.6%
2025-12-02
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-12$0.00$0.88$0.87-1.0%
2025-12-02$0.00$1.24$1.17-5.6%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$0.00$0.00
2025-09-30$0.00$0.00
2025-06-30$0.00$-2.29$2.04M+58.6%
2025-03-31$0.00$-4.02$2.04M+58.6%
2024-12-31$0.00$-4.02
2024-09-30$0.00$0.00$2.74M+382.0%
2024-06-30$-30.00$-200.00-566.7%$1.29M-28.4%
2024-03-31$-0.03$-0.20-566.7%$1.29M-90.0%
2023-12-31$-0.03$-0.20-566.7%
2023-09-30$0.00$0.00$567500.00
2023-06-30$0.26$1.80M
2023-03-31$-1.60$12.80M
2022-12-31$0.00$-0.20$12.80M

Frequently asked questions

Has Redhill Biopharma Ltd beaten earnings estimates?
Redhill Biopharma Ltd has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports.
How does RDHL stock react to earnings?
RDHL stock has moved an average of -3.3% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.